INVIMA Listed by blackbyte Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

On March 7, 2022, the Colombian regulatory agency INVIMA appeared on a leak site maintained by the BlackByte ransomware group. The listing indicated that internal files had been taken during a ransomware operation, though the number of records, the precise contents, and whether any data were later published remain undisclosed. The incident is significant because INVIMA handles regulatory oversight of medicines, medical devices, and food products, sectors in which even limited exposure of internal records can affect public-health decisions and institutional operations.

What happened

INVIMA was listed on the BlackByte ransomware leak site on March 7, 2022. The group stated that it had exfiltrated internal files during a ransomware attack. No further details on the timing of the intrusion, the method of initial access, the volume of data taken, or any ransom demand have been made public. It is not known whether the listed files were subsequently released or whether the claim of exfiltration was independently verified.

Who is blackbyte?

BlackByte is a ransomware group that emerged publicly in 2021 and employed a double-extortion model: encrypting systems and threatening to publish stolen data if a ransom was not paid. The group maintained a leak site where it listed organizations it claimed to have compromised. Public reporting has associated BlackByte with targeted attacks on mid-sized and large organizations across multiple countries, often using commodity initial-access techniques followed by data theft prior to encryption. Any specific claims the group makes about a victim are treated as unverified until corroborated by the affected organization or independent investigation.

About INVIMA

INVIMA is Colombia’s National Institute for the Surveillance of Medicines and Food, a government agency responsible for authorizing, inspecting, and monitoring pharmaceuticals, medical devices, cosmetics, and food products. Agencies of this type routinely collect and store regulatory submissions, inspection reports, laboratory results, and correspondence with manufacturers and importers. A breach at such an institution can involve records that are not inherently personal but that underpin decisions affecting public health and market access.

What was likely exposed

The only information released states that internal files were exfiltrated. No inventory of file types, no count of records, and no confirmation of personal, financial, or health data have been published. Organizations in this sector typically hold regulatory dossiers, correspondence, internal assessments, and operational documents; however, the exact contents of the material claimed by the group are unconfirmed.

Why it matters

Even without confirmed personal data, exposure of internal regulatory files can reveal inspection findings, pending authorizations, or communications that affect manufacturers, importers, and ultimately patients and consumers. For the agency, the incident may require extended forensic review, notification to oversight bodies, and adjustments to access controls. Individuals or companies referenced in the files may face indirect consequences if the material later circulates, though the scale of any such exposure is not known.

If your data was in this claimed breach

Monitor official statements from INVIMA for any guidance on affected parties. Review accounts linked to regulatory or commercial interactions with the agency for unusual activity. Individuals can run a free exposure scan of their email address against known breach datasets to check whether their information appears in other publicly reported incidents. No specific remediation steps beyond standard account monitoring have been issued in connection with this listing.

AICompiled with AI assistance from public sources and published under our editorial standards.